Clearance of extracellular misfolded proteins in systemic amyloidosis: Experience with transthyretin
Open Access
- 20 July 2012
- journal article
- review article
- Published by Wiley in FEBS Letters
- Vol. 586 (18) , 2891-2896
Abstract
Increasing evidence indicates that accumulation of misfolded proteins in the form of oligomers, protofibrils or amyloid fibrils, and their consequences in triggering intracellular signaling cascades with toxic consequences represent unifying events in many of slowly progressive neurodegenerative disorders. Studies with small compounds or molecules, known to recognize and disrupt amyloidogenic structures, have proven efficient in promoting clearance of protein aggregates in experimental models of systemic and localized forms of amyloidoses. Doxycycline and EGCG were efficient in removing aggregates in pre‐clinical studies in a transgenic mouse model for transthyretin (TTR) systemic amyloidosis and represent an opportunity to address mechanisms and key players in deposit removal. Extracellular chaperones, such as clusterin and metalloproteinases play an important role in this process.Keywords
This publication has 43 references indexed in Scilit:
- Green tea halts progression of cardiac transthyretin amyloidosis: an observational reportClinical Research in Cardiology, 2012
- Epigallocatechin-3-Gallate as a Potential Therapeutic Drug for TTR-Related Amyloidosis: “In Vivo” Evidence from FAP Mice ModelsPLOS ONE, 2012
- Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosisBlood, 2011
- Lysine-Specific Molecular Tweezers Are Broad-Spectrum Inhibitors of Assembly and Toxicity of Amyloid ProteinsJournal of the American Chemical Society, 2011
- Effect of Tetracyclines on the Dynamics of Formation and Destructuration of β2-Microglobulin Amyloid FibrilsJournal of Biological Chemistry, 2011
- Antibodies to human serum amyloid P component eliminate visceral amyloid depositsNature, 2010
- Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse modelsJournal of Translational Medicine, 2010
- EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicityProceedings of the National Academy of Sciences, 2010
- Extracellular chaperones modulate the effects of Alzheimer’s patient cerebrospinal fluid on Aβ1-42 toxicity and uptakeCell Stress and Chaperones, 2010
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomersNature Structural & Molecular Biology, 2008